|
| |
TISSUEscope Innovation Honored by Frost &
Sullivan
Waterloo, ON, Nov 30, 2005:
Biomedical Photometrics Inc. (BPI), a Canadian
laser scanning instrument manufacturer for drug discovery, pathology and
genomics research, announced today that the company has been named as recipient
of the 2005 Frost & Sullivan Technology Innovation of the Year Award in Confocal
Imaging Solutions. The Award was given to BPI for its development of the
innovative fluorescence imaging system known as TISSUEscope™.
Frost & Sullivan’s Technology Innovation Award is given to a company where new
research has resulted in innovation that has or is expected to bring significant
contributions to the industry in terms of adoption, change, and competitive
posture. This Award recognizes the quality and depth of a company’s research and
development program as well as the vision and risk-taking that enabled it to
undertake such an endeavor. The Award was presented earlier this month during
the Frost & Sullivan 2005 Excellence in Best Practices Awards Banquet in Miami,
Florida.
“We are very pleased to see the TISSUEscope recognized by a leading authority on
healthcare technology and market research as an innovative new imaging
technology”, BPI’s CEO, A.E. (Ted) Dixon commented.
About the TISSUEscope™
The TISSUEscope™ uses BPI’s patented
widefield MACROscope® technology to produce a high-resolution digital image of
an entire tissue specimen in a single scan without the time consuming process of
tiling 1000’s of tiny images. The resulting virtual slide is stored in a single
digital file, enabling low and high-resolution images of the entire tissue
specimen to be easily displayed, manipulated, distributed and interpreted.
In addition to brightfield imaging, the TISSUEscope™ has the high sensitivity
necessary to simultaneously view tissue specimens using several other contrast
mechanisms including fluorescence. Fluorescence is a growing requirement for
advanced quantitative molecular imaging needed by research pathologists for
detecting cancers and monitoring treatment. Specimen images that require
multiple contrast mechanisms that may take hours to produce with image tiling
processes can now be done with the TISSUEscope™ in minutes. Further, the
confocal characteristic of the TISSUEscope™ also allows for optical sectioning
and construction of 3-D virtual slides.
No other virtual microscopy imaging technology combines acquisition and
manipulation of brightfield and fluorescence images, wide field-of-view (more
than ten times that of a standard microscope), the ability to capture the entire
image in a single scan, and confocal imaging capability in one instrument.
About Biomedical Photometrics Inc.
Founded in 1994, Biomedical
Photometrics Inc. (BPI) develops, manufactures and markets multifunctional
scanning laser imaging systems that combine patented widefield fluorescence
confocal technology with automated functionality. BPI products are used around
the world by leading hospital, pharmaceutical, biotechnology, academic, and
government laboratories for microarray analysis, tissue and tissue array
imaging, and even imaging live specimens. Complete specifications for products
can be found at www.confocal.com .
About Frost & Sullivan
Frost & Sullivan, a global growth
consulting company, has been partnering with clients to support the development
of innovative strategies for more than 40 years. The company's industry
expertise integrates growth consulting, growth partnership services, and
corporate management training to identify and develop opportunities. Frost &
Sullivan serves an extensive clientele that includes Global 1000 companies,
emerging companies, and the investment community by providing comprehensive
industry coverage that reflects a unique global perspective and combines ongoing
analysis of markets, technologies, econometrics, and demographics. For more
information, visit http://www.frost.com .
Contact: Glenn Smith
Phone: (519) 886-9013 x38
Email: gsmith@confocal.com
Fax: (519) 886-5300
| |
|
